Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Tizanidine for Hypotonia (Reduced Muscle Tone)

Mechanism of Action and Approved Indications

  • Tizanidine is a centrally acting alpha-2 adrenergic receptor agonist that functions as a muscle relaxant specifically for treating spasticity (increased muscle tone), not hypotonia 4
  • Tizanidine is FDA-approved for treating spasticity associated with upper motor neuron syndromes such as stroke, multiple sclerosis, and spinal cord injury 1, 2

Evidence Against Use in Hypotonia

  • Clinical guidelines specifically recommend tizanidine for spasticity (increased muscle tone), which is the opposite condition to hypotonia 1, 5
  • The American Academy of Neurology guidelines recommend tizanidine for upper and lower limb spasticity to reduce excessive muscle tone, not to increase insufficient muscle tone 5

Appropriate Uses of Tizanidine

  • Tizanidine is effective for treating spasticity resulting in pain, poor skin hygiene, or decreased function in patients with upper motor neuron disorders 1, 5

Potential Harms in Hypotonia

  • Tizanidine can cause significant hypotension, which may be particularly problematic in patients with already compromised motor function 4

Alternative Approaches for Hypotonia

  • Physical therapy with strengthening exercises is the mainstay of treatment for hypotonia rather than pharmacological intervention 1
  • In cases where spasticity is severe and unresponsive to oral medications, more invasive options like botulinum toxin injections, intrathecal baclofen, or neurosurgical procedures may be considered 1, 5